NASDAQ: TIVCTivic Health Systems Inc Stock
$1.11-0.02 (-1.77%)
Updated Apr 24, 2024
TIVC Price
$1.11
Fair Value Price
N/A
Market Cap
$1.63M
52 Week Low
$1.00
52 Week High
$23.79
P/E
-0.11x
P/B
0.45x
P/S
1.21x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.18M
Earnings
-$8.24M
Gross Margin
24.4%
Operating Margin
-701.02%
Profit Margin
-701%
Debt to Equity
0.44
Operating Cash Flow
-$9M
Beta
0.67
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
TIVC Overview
Tivic Health Systems Incorporated is a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, a medical device intended to relieve sinus and nasal inflammation. The company sells its products through its own website and other online retailers. Tivic Health Systems was incorporated in 2016 and is headquartered in Hayward, CA.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TIVC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TIVC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TIVC is good value based on its book value relative to its share price (0.45x), compared to the US Medical Devices industry average (3.73x)
P/B vs Industry Valuation
TIVC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more TIVC due diligence checks available for Premium users.
Be the first to know about important TIVC news, forecast changes, insider trades & much more!
TIVC News
Valuation
TIVC fair value
Fair Value of TIVC stock based on Discounted Cash Flow (DCF)
Price
$1.11
Fair Value
$26.99
Undervalued by
95.89%
TIVC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TIVC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.11x
Industry
30.46x
Market
41.27x
TIVC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.45x
Industry
3.73x
TIVC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TIVC's financial health
Profit margin
Revenue
$357.0k
Net Income
-$2.2M
Profit Margin
-628.3%
TIVC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
TIVC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.2M
Liabilities
$1.6M
Debt to equity
0.44
TIVC's short-term assets ($4.65M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TIVC's short-term assets ($4.65M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TIVC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.8M
Investing
$0.0
Financing
$0.0
TIVC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TIVC vs Medical Device Stocks
Tivic Health Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.